Hepatitis A virus cellular receptor 1 (HAVcr-1) also known as T-cell immunoglobulin and mucin domain 1 (TIM-1) is a protein that in humans is encoded by the HAVCR1gene.[1][2][3]
It is also known as KIM-1 Kidney Injury Molecule -1, which is a protein the most highly upregulated in injured kidneys by various types of insults. Its upregulation during renal injury has been found in the kidneys of the vertebrates such as Zebrafish and humans.
The hepatitis A virus cellular receptor 1 (HAVCR1/TIM-1), is a member of the TIM (T cell transmembrane, immunoglobulin, and mucin) gene family, which plays critical roles in regulating immune cell activity especially regarding the host response to viral infection. TIM-1 is also involved in allergic response, asthma, and transplant tolerance.
The TIM gene family was first cloned from the mouse model of asthma in 2001.[2] Subsequently, it was demonstrated that members of the TIM gene family including TIM-1 participate in host immune response. The mouse TIM gene family contains eight members (TIM-1-8) while only three TIM genes (TIM-1, TIM-3, and TIM-4) have been identified in humans.
TIM genes belong to type I cell-surface glycoproteins, which include an N-terminal immunoglobulin (Ig)-like domain, a mucin domain with distinct length, a single transmembrane domain, and a C-terminal short cytoplasmic tail. The localization and functions of TIM genes are divergent between each member. TIM-1 is preferentially expressed on Th2 cells and has been identified as a stimulatory molecule for T-cell activation.[4] TIM-3 is preferentially expressed on Th1 and Tc1 cells and function as an inhibitory molecule, which mediated apoptosis of Th1 and Tc1 cells.[5] TIM-4 is preferentially expressed on antigen-presenting cells, modulating the phagocytosis of apoptotic cells by interacting with phosphatidylserine (PS) exposed on apoptotic cell surface.[6]
Role in viral infection
TIM genes are also involved in host-virus interaction. As receptors for phosphatidylserine, TIM proteins bind many families of viruses [filovirus, flavivirus, New World arenavirus and alphavirus] that include viruses such as dengue and ebola. Entry of Lassa fever virus, influenza A virus, and SARS coronavirus were not affected by TIM-1 expression. TIM-1 and TIM-4 enhanced viral entry more than TIM-3.[7]
Hepatitis A
TIM-1 has been identified as the cellular receptor of hepatitis A virus (HAV). The mucin domain and IgV domain were critical for virus uncoating and infectivity. By using an expression cloning library, IgA has been demonstrated as a specific ligand of TIM-1. The association of TIM-1 and IgA was able to enhance the virus-receptor interaction.[8]
Ebola
Recently, TIM-1 has been shown to be a receptor or cofactor for Ebola virus entry. TIM-1 binds to Ebola virus glycoproteins (GP) and mediates Ebola virus cellular entry by increasing Ebola virus infectivity in cell lines with a low susceptibility. Moreover, reducing expression of endogenous TIM-1 in highly permissive cell lines decreased Ebola virus infectivity.[9] Furthermore, TIM-1 IgV domain specific antibody ARD5 inhibited Ebola virus infectivity, indicating that TIM-1 was critical for Ebola virus entry. Also, TIM-1 expression on human mucosal epithelial cells from the trachea, cornea and conjunctiva demonstrated the correlation of TIM-1 expression feature and viral entry routes.
Dengue
TIM-1 has been identified as a cellular factor for Dengue virus entry by overexpression of TIM-1 on poorly susceptible cell lines for Dengue virus infection. TIM-1 enhanced dengue virus infectivity by 500-fold, particularly increased virus internalization. TIM-1 directly interacted with Dengue virus particle by recognizing PS on the virion surface.[10] In addition, the Dengue virus susceptibility of different cell lines was consistent with endogenous expression level of TIM-1 gene in such cell lines, suggesting that TIM-1 is crucial for Dengue virus entry.
Kumanogoh A, Kikutani H (2004). "Immune semaphorins: a new area of semaphorin research". Journal of Cell Science. 116 (Pt 17): 3463–3470. doi:10.1242/jcs.00674. PMID12893810.
McIntire JJ, Umetsu DT, DeKruyff RH (2004). "TIM-1, a novel allergy and asthma susceptibility gene". Springer Seminars in Immunopathology. 25 (3–4): 335–348. doi:10.1007/s00281-003-0141-3. PMID15007635.
Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV (2002). "Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration". Journal of Biological Chemistry. 277 (42): 39739–39748. doi:10.1074/jbc.M200562200. PMID12138159.
Noguchi E, Nakayama J, Kamioka M, Ichikawa K, Shibasaki M, Arinami T (2003). "Insertion/deletion coding polymorphisms in hHAVcr-1 are not associated with atopic asthma in the Japanese population". Genes and Immunity. 4 (2): 170–173. doi:10.1038/sj.gene.6363935. PMID12618867.
Chae SC, Song JH, Heo JC, Lee YC, Kim JW, Chung HT (2004). "Molecular variations in the promoter and coding regions of human Tim-1 gene and their association in Koreans with asthma". Human Immunology. 64 (12): 1177–1182. doi:10.1016/j.humimm.2003.09.011. PMID14630400.
Chae SC, Song JH, Lee YC, Kim JW, Chung HT (2004). "The association of the exon 4 variations of Tim-1 gene with allergic diseases in a Korean population". Biochemical and Biophysical Research Communications. 312 (2): 346–350. doi:10.1016/j.bbrc.2003.10.125. PMID14637143.
Vilà MR, Kaplan GG, Feigelstock D, Nadal M, Morote J, Porta R, Bellmunt J, Meseguer A (2004). "Hepatitis A virus receptor blocks cell differentiation and is overexpressed in clear cell renal cell carcinoma". Kidney International. 65 (5): 1761–1773. doi:10.1111/j.1523-1755.2004.00601.x. PMID15086915.
Mesri M, Smithson G, Ghatpande A, Chapoval A, Shenoy S, Boldog F, Hackett C, Pena CE, Burgess C, Bendele A, Shimkets RA, Starling GC (2006). "Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins". International Immunology. 18 (3): 473–484. doi:10.1093/intimm/dxh388. PMID16481347.
Lim J, Hao T, Shaw C, Patel AJ, Szabó G, Rual JF, Fisk CJ, Li N, Smolyar A, Hill DE, Barabási AL, Vidal M, Zoghbi HY (2006). "A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration". Cell. 125 (4): 801–814. doi:10.1016/j.cell.2006.03.032. PMID16713569.
Kotsis F, Nitschke R, Boehlke C, Bashkurov M, Walz G, Kuehn EW (2007). "Ciliary calcium signaling is modulated by kidney injury molecule-1 (Kim1)". Pflügers Archiv. 453 (6): 819–829. doi:10.1007/s00424-006-0168-0. PMID17205356.